Skip to Main Content

The pitch from Stimwave, a medical device maker, was alluring. As a startup tackling chronic pain with nerve-stimulating devices, it promised to release patients from the stranglehold of addictive painkillers. And unlike its competitors, whose devices required patients to have clunky batteries implanted in their bodies, Stimwave’s system came with a sleek, wearable battery attached to thin wires under the skin.

There was just one problem: some of the devices contained dummy pieces of plastic that did nothing at all.

advertisement

While the components were fake, they let Stimwave sell their devices for thousands of dollars more than they otherwise could. The company’s CEO, Laura Perryman, pushed the company’s staffers to lie to physicians about the plastic part being medically necessary, according to interviews with former employees and a review of court filings.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.